Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
Market Analysis and Insights: Global Combined hormonal contraceptive Market
The global Combined hormonal contraceptive market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Combined hormonal contraceptive Scope and Segment
The global Combined hormonal contraceptive market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Combined hormonal contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Pills
Patch
Ring
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Competitive Landscape:
The report provides a list of all the key players in the Combined hormonal contraceptive market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Combined hormonal contraceptive key manufacturers in this market include:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
Market Analysis and Insights: Global Combined hormonal contraceptive Market
The global Combined hormonal contraceptive market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Combined hormonal contraceptive Scope and Segment
The global Combined hormonal contraceptive market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Combined hormonal contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Pills
Patch
Ring
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Competitive Landscape:
The report provides a list of all the key players in the Combined hormonal contraceptive market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Combined hormonal contraceptive key manufacturers in this market include:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
1 Combined hormonal contraceptive Market Overview
1.1 Combined hormonal contraceptive Product Overview
1.2 Combined hormonal contraceptive Market Segment by Type
1.2.1 Pills
1.2.2 Patch
1.2.3 Ring
1.3 Global Combined hormonal contraceptive Market Size by Type
1.3.1 Global Combined hormonal contraceptive Market Size Overview by Type (2016-2027)
1.3.2 Global Combined hormonal contraceptive Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Combined hormonal contraceptive Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Combined hormonal contraceptive Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Combined hormonal contraceptive Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Combined hormonal contraceptive Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Combined hormonal contraceptive Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.2 Europe Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
2 Global Combined hormonal contraceptive Market Competition by Company
2.1 Global Top Players by Combined hormonal contraceptive Sales (2016-2021)
2.2 Global Top Players by Combined hormonal contraceptive Revenue (2016-2021)
2.3 Global Top Players Combined hormonal contraceptive Price (2016-2021)
2.4 Global Top Manufacturers Combined hormonal contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Combined hormonal contraceptive Market Competitive Situation and Trends
2.5.1 Combined hormonal contraceptive Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Combined hormonal contraceptive Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Combined hormonal contraceptive as of 2020)
2.7 Date of Key Manufacturers Enter into Combined hormonal contraceptive Market
2.8 Key Manufacturers Combined hormonal contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Combined hormonal contraceptive Status and Outlook by Region
3.1 Global Combined hormonal contraceptive Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Combined hormonal contraceptive Historic Market Size by Region
3.2.1 Global Combined hormonal contraceptive Sales in Volume by Region (2016-2021)
3.2.2 Global Combined hormonal contraceptive Sales in Value by Region (2016-2021)
3.2.3 Global Combined hormonal contraceptive Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Combined hormonal contraceptive Forecasted Market Size by Region
3.3.1 Global Combined hormonal contraceptive Sales in Volume by Region (2022-2027)
3.3.2 Global Combined hormonal contraceptive Sales in Value by Region (2022-2027)
3.3.3 Global Combined hormonal contraceptive Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Combined hormonal contraceptive by Application
4.1 Combined hormonal contraceptive Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 E-commerce
4.1.4 Others
4.2 Global Combined hormonal contraceptive Market Size by Application
4.2.1 Global Combined hormonal contraceptive Market Size Overview by Application (2016-2027)
4.2.2 Global Combined hormonal contraceptive Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Combined hormonal contraceptive Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Combined hormonal contraceptive Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Combined hormonal contraceptive Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Combined hormonal contraceptive Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Combined hormonal contraceptive Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.2 Europe Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
5 North America Combined hormonal contraceptive by Country
5.1 North America Combined hormonal contraceptive Historic Market Size by Country
5.1.1 North America Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
5.1.2 North America Combined hormonal contraceptive Sales in Value by Country (2016-2021)
5.2 North America Combined hormonal contraceptive Forecasted Market Size by Country
5.2.1 North America Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
5.2.2 North America Combined hormonal contraceptive Sales in Value by Country (2022-2027)
6 Europe Combined hormonal contraceptive by Country
6.1 Europe Combined hormonal contraceptive Historic Market Size by Country
6.1.1 Europe Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
6.1.2 Europe Combined hormonal contraceptive Sales in Value by Country (2016-2021)
6.2 Europe Combined hormonal contraceptive Forecasted Market Size by Country
6.2.1 Europe Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
6.2.2 Europe Combined hormonal contraceptive Sales in Value by Country (2022-2027)
7 Asia-Pacific Combined hormonal contraceptive by Region
7.1 Asia-Pacific Combined hormonal contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Combined hormonal contraceptive Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Combined hormonal contraceptive Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Combined hormonal contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Combined hormonal contraceptive Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Combined hormonal contraceptive Sales in Value by Region (2022-2027)
8 Latin America Combined hormonal contraceptive by Country
8.1 Latin America Combined hormonal contraceptive Historic Market Size by Country
8.1.1 Latin America Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
8.1.2 Latin America Combined hormonal contraceptive Sales in Value by Country (2016-2021)
8.2 Latin America Combined hormonal contraceptive Forecasted Market Size by Country
8.2.1 Latin America Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
8.2.2 Latin America Combined hormonal contraceptive Sales in Value by Country (2022-2027)
9 Middle East and Africa Combined hormonal contraceptive by Country
9.1 Middle East and Africa Combined hormonal contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Combined hormonal contraceptive Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Combined hormonal contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Combined hormonal contraceptive Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Combined hormonal contraceptive Business
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Corporation Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Bayer HealthCare Pharmaceuticals
10.2.1 Bayer HealthCare Pharmaceuticals Corporation Information
10.2.2 Bayer HealthCare Pharmaceuticals Introduction and Business Overview
10.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
10.2.5 Bayer HealthCare Pharmaceuticals Recent Development
10.3 Actavis
10.3.1 Actavis Corporation Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Actavis Combined hormonal contraceptive Products Offered
10.3.5 Actavis Recent Development
10.4 Pfizer
10.4.1 Pfizer Corporation Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Pfizer Combined hormonal contraceptive Products Offered
10.4.5 Pfizer Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Corporation Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Johnson & Johnson Combined hormonal contraceptive Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Corporation Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.6.4 GlaxoSmithKline Combined hormonal contraceptive Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Watson Pharma
10.7.1 Watson Pharma Corporation Information
10.7.2 Watson Pharma Introduction and Business Overview
10.7.3 Watson Pharma Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Watson Pharma Combined hormonal contraceptive Products Offered
10.7.5 Watson Pharma Recent Development
10.8 Cipla
10.8.1 Cipla Corporation Information
10.8.2 Cipla Introduction and Business Overview
10.8.3 Cipla Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Cipla Combined hormonal contraceptive Products Offered
10.8.5 Cipla Recent Development
10.9 Novartis International
10.9.1 Novartis International Corporation Information
10.9.2 Novartis International Introduction and Business Overview
10.9.3 Novartis International Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Novartis International Combined hormonal contraceptive Products Offered
10.9.5 Novartis International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Combined hormonal contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Combined hormonal contraceptive Industrial Chain Analysis
11.4 Combined hormonal contraceptive Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Combined hormonal contraceptive Distributors
12.3 Combined hormonal contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Combined hormonal contraceptive Product Overview
1.2 Combined hormonal contraceptive Market Segment by Type
1.2.1 Pills
1.2.2 Patch
1.2.3 Ring
1.3 Global Combined hormonal contraceptive Market Size by Type
1.3.1 Global Combined hormonal contraceptive Market Size Overview by Type (2016-2027)
1.3.2 Global Combined hormonal contraceptive Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Combined hormonal contraceptive Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Combined hormonal contraceptive Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Combined hormonal contraceptive Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Combined hormonal contraceptive Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Combined hormonal contraceptive Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.2 Europe Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Combined hormonal contraceptive Sales Breakdown by Type (2016-2021)
2 Global Combined hormonal contraceptive Market Competition by Company
2.1 Global Top Players by Combined hormonal contraceptive Sales (2016-2021)
2.2 Global Top Players by Combined hormonal contraceptive Revenue (2016-2021)
2.3 Global Top Players Combined hormonal contraceptive Price (2016-2021)
2.4 Global Top Manufacturers Combined hormonal contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Combined hormonal contraceptive Market Competitive Situation and Trends
2.5.1 Combined hormonal contraceptive Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Combined hormonal contraceptive Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Combined hormonal contraceptive as of 2020)
2.7 Date of Key Manufacturers Enter into Combined hormonal contraceptive Market
2.8 Key Manufacturers Combined hormonal contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Combined hormonal contraceptive Status and Outlook by Region
3.1 Global Combined hormonal contraceptive Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Combined hormonal contraceptive Historic Market Size by Region
3.2.1 Global Combined hormonal contraceptive Sales in Volume by Region (2016-2021)
3.2.2 Global Combined hormonal contraceptive Sales in Value by Region (2016-2021)
3.2.3 Global Combined hormonal contraceptive Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Combined hormonal contraceptive Forecasted Market Size by Region
3.3.1 Global Combined hormonal contraceptive Sales in Volume by Region (2022-2027)
3.3.2 Global Combined hormonal contraceptive Sales in Value by Region (2022-2027)
3.3.3 Global Combined hormonal contraceptive Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Combined hormonal contraceptive by Application
4.1 Combined hormonal contraceptive Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 E-commerce
4.1.4 Others
4.2 Global Combined hormonal contraceptive Market Size by Application
4.2.1 Global Combined hormonal contraceptive Market Size Overview by Application (2016-2027)
4.2.2 Global Combined hormonal contraceptive Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Combined hormonal contraceptive Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Combined hormonal contraceptive Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Combined hormonal contraceptive Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Combined hormonal contraceptive Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Combined hormonal contraceptive Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Combined hormonal contraceptive Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.2 Europe Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Combined hormonal contraceptive Sales Breakdown by Application (2016-2021)
5 North America Combined hormonal contraceptive by Country
5.1 North America Combined hormonal contraceptive Historic Market Size by Country
5.1.1 North America Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
5.1.2 North America Combined hormonal contraceptive Sales in Value by Country (2016-2021)
5.2 North America Combined hormonal contraceptive Forecasted Market Size by Country
5.2.1 North America Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
5.2.2 North America Combined hormonal contraceptive Sales in Value by Country (2022-2027)
6 Europe Combined hormonal contraceptive by Country
6.1 Europe Combined hormonal contraceptive Historic Market Size by Country
6.1.1 Europe Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
6.1.2 Europe Combined hormonal contraceptive Sales in Value by Country (2016-2021)
6.2 Europe Combined hormonal contraceptive Forecasted Market Size by Country
6.2.1 Europe Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
6.2.2 Europe Combined hormonal contraceptive Sales in Value by Country (2022-2027)
7 Asia-Pacific Combined hormonal contraceptive by Region
7.1 Asia-Pacific Combined hormonal contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Combined hormonal contraceptive Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Combined hormonal contraceptive Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Combined hormonal contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Combined hormonal contraceptive Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Combined hormonal contraceptive Sales in Value by Region (2022-2027)
8 Latin America Combined hormonal contraceptive by Country
8.1 Latin America Combined hormonal contraceptive Historic Market Size by Country
8.1.1 Latin America Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
8.1.2 Latin America Combined hormonal contraceptive Sales in Value by Country (2016-2021)
8.2 Latin America Combined hormonal contraceptive Forecasted Market Size by Country
8.2.1 Latin America Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
8.2.2 Latin America Combined hormonal contraceptive Sales in Value by Country (2022-2027)
9 Middle East and Africa Combined hormonal contraceptive by Country
9.1 Middle East and Africa Combined hormonal contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Combined hormonal contraceptive Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Combined hormonal contraceptive Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Combined hormonal contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Combined hormonal contraceptive Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Combined hormonal contraceptive Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Combined hormonal contraceptive Business
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Corporation Information
10.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.1.3 Teva Pharmaceutical Industries Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Bayer HealthCare Pharmaceuticals
10.2.1 Bayer HealthCare Pharmaceuticals Corporation Information
10.2.2 Bayer HealthCare Pharmaceuticals Introduction and Business Overview
10.2.3 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
10.2.5 Bayer HealthCare Pharmaceuticals Recent Development
10.3 Actavis
10.3.1 Actavis Corporation Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Actavis Combined hormonal contraceptive Products Offered
10.3.5 Actavis Recent Development
10.4 Pfizer
10.4.1 Pfizer Corporation Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Pfizer Combined hormonal contraceptive Products Offered
10.4.5 Pfizer Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Corporation Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Johnson & Johnson Combined hormonal contraceptive Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Corporation Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.6.4 GlaxoSmithKline Combined hormonal contraceptive Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Watson Pharma
10.7.1 Watson Pharma Corporation Information
10.7.2 Watson Pharma Introduction and Business Overview
10.7.3 Watson Pharma Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Watson Pharma Combined hormonal contraceptive Products Offered
10.7.5 Watson Pharma Recent Development
10.8 Cipla
10.8.1 Cipla Corporation Information
10.8.2 Cipla Introduction and Business Overview
10.8.3 Cipla Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Cipla Combined hormonal contraceptive Products Offered
10.8.5 Cipla Recent Development
10.9 Novartis International
10.9.1 Novartis International Corporation Information
10.9.2 Novartis International Introduction and Business Overview
10.9.3 Novartis International Combined hormonal contraceptive Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Novartis International Combined hormonal contraceptive Products Offered
10.9.5 Novartis International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Combined hormonal contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Combined hormonal contraceptive Industrial Chain Analysis
11.4 Combined hormonal contraceptive Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Combined hormonal contraceptive Distributors
12.3 Combined hormonal contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
